↓ Skip to main content

Dove Medical Press

HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia

Overview of attention for article published in Drug Design, Development and Therapy, January 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
220 Mendeley
Title
HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia
Published in
Drug Design, Development and Therapy, January 2015
DOI 10.2147/dddt.s75056
Pubmed ID
Authors

Gunasekaran Baskaran, Shamala Salvamani, Siti Aqlima Ahmad, Noor Azmi Shaharuddin, Parveen Devi Pattiram, Mohd Yunus Shukor

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 <1%
Unknown 219 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 13%
Student > Master 27 12%
Student > Ph. D. Student 21 10%
Lecturer 14 6%
Researcher 13 6%
Other 30 14%
Unknown 86 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 36 16%
Agricultural and Biological Sciences 25 11%
Pharmacology, Toxicology and Pharmaceutical Science 16 7%
Chemistry 15 7%
Medicine and Dentistry 12 5%
Other 24 11%
Unknown 92 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2020.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#642
of 2,268 outputs
Outputs of similar age
#110,289
of 359,538 outputs
Outputs of similar age from Drug Design, Development and Therapy
#19
of 57 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,538 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.